Sunday November 17, 2019

Can a Patient without Donors advertise for Transplantation?

Delhi High court was faced with the question; Can a common citizen without a donor for transplantcan use the help of media to advertise for his/her cause?

0
//
Doctors (representational Image), Pixabay

New Delhi, Mar 4, 2017:  Can the authorities allow a person who has no family donor to advertise to get a volunteer for a kidney transplant? This is a question on which the Delhi High Court looked for the views of the government on Feb 28, this year.

The patient who raised the issue drew the attention of the court to the fact that it is easy in case of celebrities or well-known public figures to get volunteer donors because of media attention but common citizens do not have a right to avail the benefit of such media advertisements.

NewsGram brings to you latest new stories in India.

Seized with the matter, Justice Sanjeev Sachdeva, asked the Ministry for Family Health and Welfare to look into various aspects related to the transplantation of kidney raised by the petitioner.

According to PTI reports, The judge also sought the opinion of the National Organ and Tissue Transplant Organisation (NOTTO), the All India Institute of Medical Sciences (AIIMS) and  the apex centre for registry, procurement and distribution of organs and tissues on the plea of the patient who has narrated his ordeal of 15 long years.

Go to NewsGram and check out news related to political current issues.

NOTTO’s response was sought as the patient has prayed for scrapping of the body which maintains a registry of donations and transplantation of tissues and organs.

The patient named Vinod Kumar Anand, has suffered the loss of both of his kidneys and the one donated by his wife due to renal problems.

During the hearing, the patient’s advocate, Ashok Aggarwal, was asked by the court to explore the possibility of kidney exchange between his family and that of someone else who also required the organ.

Kidney exchange or ‘swap’ is a simple barter system in which a swap pair consists of a recipient (patient) and a donor (a family member). A swap transplant like this involves an exchange of organs between two families, who cannot donate the organ to their own family member due to the mismatch of a blood group.

– prepared by Durba Mandal of NewsGram. Twitter: @dubumerang

 

Next Story

Delhi High Court Directs Private Clinic to Continue with the Stem Cell Treatment

The clinic, which is administering the medicine, cannot function under the new rules until the licence is duly obtained

0
Order
Delhi High Court. Source- Wikimedia

In an interim relief, the Delhi High Court has directed a private clinic to continue with the stem cell treatment being provided to the patients till its further orders.

The court’s interim direction came while hearing various petitions challenging the Centre’s decision to put stem cell therapy in the category of new drugs.

The petitioners were being provided stem cell treatment in Nutech Mediworld Clinic in Green Park here.

A Division Bench of justices Anu Malhotra and Talwant Singh said that all details of treatment being provided to the petitioners by the clinic be placed on record with an affidavit.

Representational image.

The court has sought the response of Centre and Indian Council of Medical Research to file reply on the petition and listed the matter for September 4 for further hearing.

The court has directed authorities concerned to examine whether the products being administered to the petitioners, prima facie, fall within the scope of the expression ‘new drugs’ as defined under Rule 2(1) (w) of New Drugs and Clinical Trial Rules, 2019 and communicate the view to the petitioners and the said clinic.

Also Read- LG CNS, Microsoft to Develop Cloud-based Enterprise Solutions

On account of the Centre’s fresh notification on ‘New Drugs and Clinical Rule 2019’, some medications used for the treatment would fall under the definition of ‘new drug’ and require approval from the authority concerned.

The clinic, which is administering the medicine, cannot function under the new rules until the licence is duly obtained. (IANS)